Agile Therapeutics, Inc. Long-term Debt, Gross
Agile Therapeutics, Inc. had Long-term Debt, Gross of $1.65 million as of 2023-12-31, per its 10-Q filed 2024-08-12.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentCarryingAmount · last filed 2024-08-12
- 2023-12-31: Long-term Debt, Gross $1.65M.
- 2023-09-30: Long-term Debt, Gross $1.95M.
- 2023-06-30: Long-term Debt, Gross $2.17M.
- 2023-03-31: Long-term Debt, Gross $2.40M.
| Period end | Long-term Debt, Gross |
|---|---|
| 2023-12-31 | $1.65M 10-Q · filed 2024-08-12 |
| 2023-09-30 | $1.95M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $2.17M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $2.40M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $2.63M 10-K · filed 2024-03-28 |
| 2022-09-30 | $2.85M 10-Q · filed 2022-11-07 |
| 2022-06-30 | $15.00M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $15.00M 10-Q · filed 2022-05-12 |
| 2021-12-31 | $20.00M 10-K · filed 2023-03-23 |
| 2021-09-30 | $20.00M 10-Q/A · filed 2021-12-30 |
| 2021-06-30 | $20.00M 10-Q · filed 2021-07-26 |
| 2021-03-31 | $20.00M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $20.00M 10-K · filed 2022-03-30 |
| 2020-09-30 | $20.00M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $20.00M 10-Q · filed 2020-08-11 |
| 2020-03-31 | $20.00M 10-Q · filed 2020-05-05 |
| 2015-12-31 | $16.50M 10-K · filed 2016-03-09 |